Corporate Board Profile
Tech Score: 36/100
4 mention(s) identify GARY L. WILCOX as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| DAILY JOURNAL CORP | 2011-12-21 | Mr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its Sustain case management software business. | Has extensive experience in biotechnology and drug discovery companies, including operational roles in companies that develop software products (Sustain case management software). This indicates relevant technical experience adjacent to software development. |
| DAILY JOURNAL CORP | 2014-07-25 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. | Has extensive experience in biotechnology companies and is expected to help expand the company's case management software business, indicating familiarity with software and technical operations. |
| DAILY JOURNAL CORP | 2015-01-28 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. | Has extensive experience in biotechnology companies and is expected to help expand the company's case management software business, indicating familiarity with software and technical operations. |
| DAILY JOURNAL CORP | 2015-12-29 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. | Has experience in biotechnology companies and is expected to help expand the company's case management software business, indicating familiarity with software and technical operations. |
| Filing Date | Source Excerpt |
|---|---|
| 2011-12-21 | Mr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its Sustain case management software business. |
| 2012-12-21 | Since 2007, Mr. Wilcox has been the Chairman and CEO of Cocrystal Discovery, Inc., a private therapeutic drug discovery and development company. From 1993 until 2007, he was Executive Vice President, Operations and a director of Icos Corporation, a publicly traded biotechnology company. |
| 2014-07-25 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. |
| 2015-01-28 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. |
| 2015-12-29 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance is expected to be particularly helpful as the Company works to expand its case management software business. |
| 2016-12-29 | Dr. Wilcox has been the Vice Chairman of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases, since March 2015 and has been serving as Interim CEO since July 2016. He also served as Chairman and CEO of Cocrystal from January 2014 until March 2015, and as Chairman from 2007 to 2015 and CEO from 2008 to 2015 of Cocrystal’s predecessor entities. |
| 2017-12-28 | Dr. Wilcox has been the Vice Chairman of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases, since March 2015, and has been serving as Interim CEO since July 2016. He also served as Chairman and CEO of Cocrystal from January 2014 until March 2015, and as its Chairman from 2007 to 2015, and as CEO of Cocrystal’s predecessor entities from 2008 to 2015. Qualifications and Skills: Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance has been particularly helpful as the Company works to expand its case management software business. |
| 2018-12-28 | Dr. Wilcox has extensive experience building and growing start-up ventures into successful public companies. His guidance has been particularly helpful as the Company works to expand its case management software business. Dr. Wilcox has also served on other public company boards and has experience both as a CEO and as an operational executive. |
| 2019-04-01 | Gary L. Wilcox is listed as a director but there is no mention of any software-related technical skills or background. |
| 2019-12-27 | Dr. Wilcox has been the Vice Chairman of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases, since March 2015, and he served as Interim CEO from July 2016 until becoming CEO in January 2019. He also served as Chairman and CEO of Cocrystal from January 2014 until March 2015, and as its Chairman from 2007 to 2015, and as CEO of Cocrystal’s predecessor entities from 2008 to 2015. |
| 2021-01-11 | Gary L. Wilcox joined the Board of Directors in 2012. Dr. Wilcox has been Chairman of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases, since February 2020, and its Chief Executive Officer since July 2016. |
Data sourced from SEC filings. Last updated: 2025-07-01